This Event is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Event: 2202
Key Event Title
Altered expression of cell cycle genes
Short name
Biological Context
Level of Biological Organization |
---|
Molecular |
Cell term
Organ term
Key Event Components
Key Event Overview
AOPs Including This Key Event
AOP Name | Role of event in AOP | Point of Contact | Author Status | OECD Status |
---|---|---|---|---|
RAR agonism during neurodevelopment leading to impaired learning and memory | KeyEvent | Diana Lupu (send email) | Under development: Not open for comment. Do not cite | |
RAR agonism during neurodevelopment leading to microcephaly | KeyEvent | Diana Lupu (send email) | Under development: Not open for comment. Do not cite | |
GR and DNT | KeyEvent | Marie-Gabrielle Zurich (send email) | Under development: Not open for comment. Do not cite |
Taxonomic Applicability
Life Stages
Sex Applicability
Key Event Description
The eukaryotic cell cycle is divided into phases, comprising the interphase (G1, S, and G2) and the mitotic (M) phase. Under certain conditions, cells can exit the cycle and reversibly enter a state of quiescence (the G0 phase), terminally differentiate or enter a senescent state (Kumari and Jat 2021).
During cell division, the cells can progress through the cycle if they pass three major checkpoints (in G1-to-S, G2-to-M and M-to-G1), which ensure that the resulting daughter cells are healthy. The passage through successive phases is driven by cyclins and cyclin-dependent kinase (CDK) complexes (Murray, 2004). Cyclins are divided into 4 groups (A-, B-, D-, and E-cyclins) and CDKs include at least 11 proteins (Murray, 2004; Hochegger et al., 2008; Malumbres, 2009). However, there are two different perspectives as to how the cyclin-Cdk complexes temporally regulate events during the cell cycle (Hochegger et al., 2008). One model asserts that the correct completion of the S and M phases is brought about through different biochemical activities of cyclin-cdk heterodimers associated with each phase. In this view, the various cyclin-CDK complexes appear in a specific temporal sequence and target different substrates to drive progression through the cell cycle (van den Heuvel and Harlow, 1993; Sherr, 1993; Pagliuca et al., 2011). On the other hand, a second model proposes that it is the progressive increase in total CDK cell activity that drives the cell cycle, rather than CDK substrate specificity. In this view, substrates in the DNA replication phase are phosphorylated at a lower total CDK activity level than substrates in the mitotic phase (Swaffer et al., 2016). Recently, Basu et al., have reconciled these two opposing perspectives into a unitary framework which proposes a quantitative view of core CDK cell cycle control with a minor qualitative element (Basu et al., 2022). Using phosphoproteomics to study in vivo CDK activity in fission yeast, the authors show that cyclin-CDK complexes are not completely specialised for either S or M phase, and that increasing the CDK activity of S phase dimers is sufficient to carry out mitosis (Basu et al., 2022).
How It Is Measured or Detected
How it is measured or detected
Expression of cyclins and Cdks at various phases of the cell cycle can be performed at the transcript or protein level. The mRNA content of specific cyclins and Cdks can be measured using qPCR, or in the context of a more global analysis using microarray or RNAseq methods (see for e.g. Karsten et al., 2003; Kowalczyk et al., 2015; Cheroni et al., 2022). The protein amount of individual Cdks, cyclins, as well as their phosphorylated forms can be detected using immunodetection methods such as western blotting or enzyme-linked immunosorbent assays (ELISAs), as well as through mass spectrometric approaches (see for e.g. Frisa and Jacobberger, 2009; Basu et al., 2022).
Domain of Applicability
References
1. Kumari R, Jat P. Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype. Front Cell Dev Biol. 2021;9:645593.
2. Murray AW. Recycling the cell cycle: cyclins revisited. Cell. 2004;116(2):221-34.
3. Hochegger H, Takeda S, Hunt T. Cyclin-dependent kinases and cell-cycle transitions: does one fit all? Nat Rev Mol Cell Biol. 2008;9(11):910-6.
4. Malumbres M, Harlow E, Hunt T, Hunter T, Lahti JM, Manning G, et al. Cyclin-dependent kinases: a family portrait. Nat Cell Biol. 2009;11(11):1275-6.
5. van den Heuvel S, Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science. 1993;262(5142):2050-4.
6. Sherr CJ. Mammalian G1 cyclins. Cell. 1993;73(6):1059-65.
7. Pagliuca FW, Collins MO, Lichawska A, Zegerman P, Choudhary JS, Pines J. Quantitative proteomics reveals the basis for the biochemical specificity of the cell-cycle machinery. Mol Cell. 2011;43(3):406-17.
8. Swaffer MP, Jones AW, Flynn HR, Snijders AP, Nurse P. CDK Substrate Phosphorylation and Ordering the Cell Cycle. Cell. 2016;167(7):1750-61.e16.
9. Basu S, Greenwood J, Jones AW, Nurse P. Core control principles of the eukaryotic cell cycle. Nature. 2022;607(7918):381-6.
10. Karsten SL, Kudo LC, Jackson R, Sabatti C, Kornblum HI, Geschwind DH. Global analysis of gene expression in neural progenitors reveals specific cell-cycle, signaling, and metabolic networks. Dev Biol. 2003;261(1):165-82.
11. Kowalczyk MS, Tirosh I, Heckl D, Rao TN, Dixit A, Haas BJ, et al. Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cells. Genome Res. 2015;25(12):1860-72.
12. Cheroni C, Trattaro S, Caporale N, López-Tobón A, Tenderini E, Sebastiani S, et al. Benchmarking brain organoid recapitulation of fetal corticogenesis. Transl Psychiatry. 2022;12(1):520.
13. Frisa PS, Jacobberger JW. Cell cycle-related cyclin b1 quantification. PLoS One. 2009;4(9):e7064